Neervannan Seshadri sold TARS
March 20, 2026 · Form 4 insider transaction
Neervannan Seshadri sold 2,989 shares of Tarsus Pharmaceuticals, Inc. at $66.75 per share, a transaction worth $199.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,989
Price
$66.75
Total value
$199.5K
InsiderNeervannan Seshadri
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 20, 2026
Filing dateMarch 24, 2026
Shares owned after82,791
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2025.